TEV-48574

· Teva Branded Pharmaceutical Products R&D LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TEV-48574, covering 2023-03-13 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]

See pricing